This program is supported by independent educational grants from US WorldMeds, LLC, Acorda Therapeutics, Inc., Medtronic and Lundbeck, LLC.

WHY INTERVENE?

Currently, there is no cure for Parkinson's disease (PD), but a variety of medications provide symptomatic relief. As a chronic disease, PD persists over a long period of time, and as a progressive disease, its symptoms will inevitably grow worse over time. Some patients with PD become severely disabled, while others experience only minor motor disruptions. Unfortunately, no one can predict which symptoms will affect an individual patient, nor can they predict the severity of symptoms. This unpredictability makes both short- and long-term management of PD particularly difficult for clinicians.

As the baby-boom generation continues to grow older, the prevalence of PD is likely to increase. Early detection and prompt referral to a neurologic specialist can improve prompt initiation of treatment. Additionally, a clear understanding of treatment options – from levodopa to adjuncts to combination therapy – can help ensure that patients are offered the most sound and individualized options for their own personal cases. Unfortunately, there are several gaps in the detection and management of PD. Ultimately, we aim to educate clinicians routinely managing PD, and our program will aim to address several gaps in PD management in order to improve standards of care in this area.

FACULTY

Marie Saint-Hilaire

Course Director
Professor of Neurology
Boston University School of Medicine
Medical Director of the Parkinson’s Disease and Movement Disorders Center and the APDA Center for Advanced Research
Boston University Medical Center

Stephanie Bissonnette, DO, MPH

Course Co-Director
Director, Global Health Initiative
Department of Neurology
Boston Medical Center
Assistant Professor of Neurology
Boston University School of Medicine

Leah Taffel, MD

Instructor of Medicine
Boston University School of Medicine
Department of Medicine, Section of Geriatrics
Boston Medical Center

Cathi Thomas, RN, MSN, CRNP

CNE Course Advisor
Assistant Clinical Professor of Neurology
Program Director, Parkinson’s Disease and Movement Disorders Center
Coordinator, American Parkinson Disease Association Information & Referral Center
Boston University Medical Center

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

  • Review the early symptoms of Parkinson’s disease (PD) in order to establish diagnosis sooner in the process.
  • Identify the criteria for prodromal PD in order to better understand both the motor and non-motor symptoms of the disease.
  • Assess the current landscape of PD therapeutic management, focusing on new and established therapies and guideline-based strategies.

TARGET AUDIENCE

This curriculum will target key members of the PD patient care team including: neurologists, neurology fellows, primary care physicians (PCP’s), nurse practitioners (NP’s), physicians assistants (PA’s), nurses, and other relevant clinicians

DISCLOSURES

BUSM Disclosure Policy

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Marie Saint-Hilaire, MD, Course Director, receives research funding from Acorda and Biogen.

Stephanie Bissonnette, DO, Co-Course Director, is a consultant for sRNAnylitics.

Leah Taffel, MD, speaker and planner, has no relevant financial disclosures.

Cathi Thomas, RN, CNE Course Advisor, is a consultant for Delsys, Inc.

Cammie Townsend, DNP, MS/MBA, RN, Lead Nurse Planner, Elizabeth Drury, Program Manager and Chris Drury, MS, have no relevant financial relationships to disclose.

Faculty will discuss off-label use of medications.

Release Date: December 1, 2018

Expiration: November 30, 2019

SUPPORT

This program is supported by independent educational grants from US WorldMeds, LLC, Acorda Therapeutics, Inc., Medtronic and Lundbeck, LLC.

ACCREDITATION SUPPORT

ACCME

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

ANCC

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Both live and enduring Internet activities will be approved for 1.0 ANCC contact hours and will be eligible for pharmacology credit.

HOW TO OBTAIN CREDIT

In order to successfully complete this activity, you are required to view/read the entire recording and complete the posttest and evaluation. CME / CNE credit will be awarded provided a score of 70% or better is achieved. A certificate of credit for immediate download will be available to those who successfully complete the examination.

MOC CREDIT: Your information will be sent directly to the ABIM through the Boston University School of Medicine, Continuing Medical Education Department’s reporting system. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

DISCLAIMER

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

© Trustees of Boston University, 2018